These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 12173784

  • 1. CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.
    Lam YW, Gaedigk A, Ereshefsky L, Alfaro CL, Simpson J.
    Pharmacotherapy; 2002 Aug; 22(8):1001-6. PubMed ID: 12173784
    [Abstract] [Full Text] [Related]

  • 2. CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.
    Alfaro CL, Lam YW, Simpson J, Ereshefsky L.
    J Clin Pharmacol; 2000 Jan; 40(1):58-66. PubMed ID: 10631623
    [Abstract] [Full Text] [Related]

  • 3. Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo.
    Ozdemir V, Naranjo CA, Shulman RW, Herrmann N, Sellers EM, Reed K, Kalow W.
    J Clin Psychopharmacol; 1998 Jun; 18(3):198-207. PubMed ID: 9617978
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline.
    Alfaro CL, Lam YW, Simpson J, Ereshefsky L.
    J Clin Psychopharmacol; 1999 Apr; 19(2):155-63. PubMed ID: 10211917
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.
    Ereshefsky L, Riesenman C, Lam YW.
    Clin Pharmacokinet; 1995 Apr; 29 Suppl 1():10-8; discussion 18-9. PubMed ID: 8846618
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.
    Jeppesen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brøsen K.
    Eur J Clin Pharmacol; 1996 Apr; 51(1):73-8. PubMed ID: 8880055
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline.
    Preskorn SH, Shah R, Neff M, Golbeck AL, Choi J.
    J Psychiatr Pract; 2007 Jan; 13(1):5-12. PubMed ID: 17242587
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of selective serotonin reuptake inhibitors.
    Hiemke C, Härtter S.
    Pharmacol Ther; 2000 Jan; 85(1):11-28. PubMed ID: 10674711
    [Abstract] [Full Text] [Related]

  • 13. Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans.
    Kuhn UD, Kirsch M, Merkel U, Eberhardt AM, Wenda B, Maurer I, Härtter S, Hiemke C, Volz HP, Balogh A.
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):36-46. PubMed ID: 17256449
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers.
    Skinner MH, Kuan HY, Pan A, Sathirakul K, Knadler MP, Gonzales CR, Yeo KP, Reddy S, Lim M, Ayan-Oshodi M, Wise SD.
    Clin Pharmacol Ther; 2003 Mar; 73(3):170-7. PubMed ID: 12621382
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers.
    Wilner KD, Demattos SB, Anziano RJ, Apseloff G, Gerber N.
    Br J Clin Pharmacol; 2000 Mar; 49 Suppl 1(Suppl 1):43S-47S. PubMed ID: 10771453
    [Abstract] [Full Text] [Related]

  • 19. Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine.
    Luong TT, Powers CN, Reinhardt BJ, Weina PJ.
    Curr Res Pharmacol Drug Discov; 2022 Mar; 3():100112. PubMed ID: 35756846
    [Abstract] [Full Text] [Related]

  • 20. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
    Crewe HK, Lennard MS, Tucker GT, Woods FR, Haddock RE.
    Br J Clin Pharmacol; 1992 Sep; 34(3):262-5. PubMed ID: 1389951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.